ZANUS, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 18.525
EU - Europa 3.440
AS - Asia 2.318
SA - Sud America 37
AF - Africa 24
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 24.363
Nazione #
US - Stati Uniti d'America 18.475
IT - Italia 1.588
CN - Cina 1.024
SG - Singapore 889
FI - Finlandia 437
FR - Francia 319
DE - Germania 260
SE - Svezia 250
VN - Vietnam 227
UA - Ucraina 215
GB - Regno Unito 157
IN - India 74
IE - Irlanda 44
NL - Olanda 38
RU - Federazione Russa 32
CA - Canada 29
HK - Hong Kong 26
ES - Italia 21
PH - Filippine 19
BR - Brasile 16
AU - Australia 12
GR - Grecia 12
PL - Polonia 12
ID - Indonesia 10
MX - Messico 10
PT - Portogallo 10
BE - Belgio 9
JP - Giappone 8
EC - Ecuador 7
AT - Austria 6
NG - Nigeria 6
BZ - Belize 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
MY - Malesia 5
NZ - Nuova Zelanda 5
SC - Seychelles 5
CL - Cile 4
IR - Iran 4
PE - Perù 4
RO - Romania 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
IL - Israele 3
MA - Marocco 3
NO - Norvegia 3
RS - Serbia 3
SA - Arabia Saudita 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
GH - Ghana 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PK - Pakistan 2
SI - Slovenia 2
TH - Thailandia 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
DZ - Algeria 1
EG - Egitto 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
LT - Lituania 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SZ - Regno dello Swaziland 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 24.363
Città #
Fairfield 2.850
Woodbridge 1.675
Chandler 1.607
Houston 1.399
Ann Arbor 1.322
Ashburn 1.194
Seattle 1.062
Wilmington 954
Cambridge 945
Jacksonville 754
Singapore 693
Boardman 459
Santa Clara 426
Princeton 395
San Diego 350
Des Moines 321
Padova 260
Beijing 230
Dong Ket 224
Helsinki 205
Medford 205
Nanjing 145
Roxbury 140
Milan 73
Guangzhou 70
Shenyang 60
Nanchang 57
New York 52
Falls Church 50
Rome 42
Dublin 40
Dearborn 39
Hebei 39
Jiaxing 37
London 37
Changsha 34
Bologna 29
Norwalk 29
Jinan 28
Shanghai 28
Tianjin 26
Chicago 24
Hong Kong 24
Ogden 24
Redwood City 24
Paris 22
Florence 19
Lappeenranta 19
Los Angeles 18
Munich 17
San Jose 17
Pune 16
Boisar 15
Mestre 15
Bari 14
Las Vegas 14
Vicenza 14
Verona 13
Brescia 12
Hefei 12
Kharkiv 12
Kunming 12
Ningbo 12
Portici 12
Selvazzano Dentro 12
Zhengzhou 12
Dallas 11
Kilburn 11
Mira 11
Naples 10
Buffalo 9
Detroit 9
Indiana 9
Napoli 9
Palermo 9
Pescara 9
Redmond 9
Rockville 9
Taizhou 9
Trento 9
Catania 8
Chiswick 8
Hangzhou 8
Lanzhou 8
Modena 8
Prescot 8
Treviso 8
Venezia 8
Venice 8
Amsterdam 7
Essen 7
Legnaro 7
Porto 7
Prato 7
Quito 7
Southwark 7
Toronto 7
Udine 7
Washington 7
Ancona 6
Totale 19.271
Nome #
TRAPIANTO DI FEGATO CON EMITRASPOSIZIONE PORTO-CAVALE IN PAZIENTE CON BASM SYNDROME 690
Salvataggio d’organo attraverso emitrasposizione porto-cavale in trombosi porto-spleno- meseraica acuta dopo OLTx
G. 240
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries 216
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 184
Termoablazione con microonde nel trattamento della recidiva locale di epatocarcinoma dopo trapianto ortotopico di fegato.
 182
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 181
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 169
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 163
Alcohol abuse and de novo tumors in liver transplantation 161
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 157
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 156
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 154
Use of N-acetylcysteine during liver procurement: A prospective randomized controlled study. 154
Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. 152
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 150
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 148
Prospective validation of the Barcelona Clinic Liver Cancer staging system 147
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance 146
A New Liver Autotransplantation Technique Using Subnormothermic Machine Perfusion for Organ Preservation in a Porcine Model 145
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 144
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 143
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. 139
A new experimental model of isolated perfused pig liver to support acute hepaticfailure. 138
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 134
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing 134
Reply: The easiest way to improve the outcome of suboptimal liver grafts 133
Hepatitis C Virus Adversely Affects Quality of Life 132
The survival benefit of liver transplantation in hepatocellular carcinoma patients 131
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 131
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? 129
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 129
A comparative prospective study of two available solutions for kidney and liver preservation 128
Liver Resection Associated With Mini Porto-Caval Shunt as Salvage Treatment in Patients With Progression of Hepatocellular Carcinoma Before Liver Transplantation: A Case Report 127
Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study 127
Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long? 125
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 124
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 124
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 124
Covert hepatic encephalopathy: agreement and predictive validity of different indices 123
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 123
Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study 123
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 122
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. 122
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report. 122
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 121
Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. 121
Syngeneic living-donor liver transplantation for hemangioendothelioma: a clinical model for studying liver regeneration 120
EXTREME MARGINAL DONOR: SEVERE HYPOTHERMIA AS A RARE PRESERVATION CONDITION FOR EXPLANTABLE ORGANS - A CASE REPORT 119
Meld-na and Survival Benefit In Liver Transplantation 119
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 118
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 117
Central Nervous System Infectious Complications Early After Liver Transplantation 116
TRAPIANTO DI FEGATO PER EPATOCOLANGIOCARCINOMA INCIDENTALE: ESPERIENZA DI CENTRO 116
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 116
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection 115
Videolaparoscopic microwave ablation in patients with HCC at a European high-volume center: Results of 815 procedures 115
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. 114
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 114
Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation 113
Endoscopic treatment of bile duct complications after orthotopic livertransplantation. 112
Liver transplantation for the management of hepatoblastoma 112
Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma 112
Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins 112
Perianal tailgut cyst 110
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 109
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 109
A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy. 108
Intensive Care Unit Admission of Decompensated Cirrhotic Patients: Prognostic Scoring Systems 108
LAPAROSCOPIC ABLATION AND SALVAGE TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA 108
Expression of squamous cell carcinoma antigen in hepatocellular carcinoma and its precursors 107
Neoadjuvant Therapy Protocol and Liver Transplantation in Combination With Pancreatoduodenectomy for the Treatment of Hilar Cholangiocarcinoma Occurring in a Case of Primary Sclerosing Cholangitis: Case Report With a More Than 8-Year Disease-Free Survival 107
Long-term follow-up after liver transplantation for blunt hepatic trauma 106
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 106
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation 106
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma 106
Multimodal therapy before liver transplantation for hepatocellular carcinoma. 106
Blunt liver injury: from non-operative management to liver transplantation 105
De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2008 105
Sequential versus "ab initio" combined diuretic treatment of moderate ascites in cirrhotic patients: Preliminary results of a randomized controlled multicenter clinical study 104
THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA 104
Split and whole liver transplantation outcomes: a comparative cohort study. 104
Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature. 104
Liver Retransplantation for Hepatic Abscess Due to Hepatic Artery Thrombosis: A Case Report 104
The survival benefit of laparoscopic ablation over trans-arterial chemoembolization in patients with hepatocellular carcinoma ineligible for liver resection or percutaneous ablation 104
Combined liver and kidney transplantation: analysis of Padova experience. 103
Risk Factors for Early Mortality in Liver Transplant Patients 103
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 102
Is apoptosis of vascular smooth muscle cells involved in the development of Takayasu arteritis? Suggestions from a case report 102
ESTIMATION OF THE HARM TO THE WAITING LIST AS CRUCIAL FACTOR IN THE SELECTION OF PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION 101
Comparison Between Nifedipine and Carvedilol in the Treatment of de novo Arterial Hypertension After Liver Transplantation: Preliminary Results of a Controlled Clinical Trial 101
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 101
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma 101
Pegylated Liposomal Doxorubicin and Gemcitabine in Patients With Advanced Hepatocellular Carcinoma Results of a Phase 2 Study 101
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. 100
Risk Factors in Liver Retransplantation: A Single-Center Experience RID D-7140-2011 100
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 100
Cytopathological findings in a siderotic liver nodule 100
Laparoscopic treatment of simple hepatic cysts and polycystic liver disease 100
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation. 99
Liver transplantation using suboptimal grafts: impact of donor harvesting technique. 99
Totale 12.971
Categoria #
all - tutte 90.383
article - articoli 74.167
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.612 0 0 0 0 0 319 374 456 422 506 293 242
2020/20213.636 187 382 142 295 119 331 150 310 446 325 376 573
2021/20224.569 169 500 508 249 184 299 739 377 265 73 488 718
2022/20233.556 630 348 130 374 595 565 59 224 383 36 155 57
2023/20242.049 125 274 166 170 122 159 155 156 96 141 237 248
2024/20252.425 81 545 366 265 926 242 0 0 0 0 0 0
Totale 24.634